APPOS Los Angeles - Pasadena 2024

January 19th - 20th

Hilton Pasadena Hotel

The APP Oncology Summit is Returning to Los Angeles!

An Los Angeles Oncology Conference for Oncology Clinicians

APP Oncology Summits are developed with and for advanced practice providers including NPs, PAs, pharmacists (and RNs).

As part of the multidisciplinary team in the care of cancer patients, students, physicians, and other healthcare professionals involved in the management of cancer patients are also welcome to attend.

Early Bird

$ 65
  • Through Nov 2

Advanced

$ 90
  • Through Dec 19

General

$ 115
  • Through Jan 19

Save Your Spot

REGISTER TODAY

Students, Fellows, and Industry Employees, see pricing below.  Register early to guarantee your spot!

Students - Fellows (Free Admission)

Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact info@horizoncme.com for further information.

Industry Employee - $300+

Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).

Course Overview

The APP Oncology Summit is a two-day conference designed to provide advanced practice providers (APPs) with the latest evidence-based strategies to optimize care and outcomes for patients with cancer. This conference is planned with and for advanced practice providers (NPs, PAs, pharmacists, and nurse specialists) and is a collaborative effort of oncology clinicians from multiple organizations in each community. 

The APP Oncology Summit offers a unique opportunity for APPs from various healthcare teams in the community to collaborate, learn from each other and national faculty, and share best practices on a range of issues related to the care of cancer patients.

Intended Learners

APP Oncology Summits are developed with and for advanced practice providers including NPs, PAs, pharmacists, and nurses.

As part of the multidisciplinary team in the care of cancer patients, students, physicians, and other healthcare professionals involved in the management of cancer patients are also welcome to attend.

COVID-19 & Health Safety

In alignment with recent updates to national COVID-19 guidelines and mandates, APPOS will no longer be requiring attendees to wear masks or show proof of vaccination. Masks are still encouraged for those who are at higher risk from COVID-19, including those who are unvaccinated, or immunocompromised.

Please note, that we will continue to monitor CDC, state, and local guidelines, and will keep you informed of any additional changes or updates that may impact APPOS.  

Precautions That We Take:

  • Common areas sanitized frequently
  • Personal hand sanitizer bottles distributed (when available)
  • Hand Sanitizer Stations provided throughout the show
  • We encourage Social Distancing

2024 Conference Planning Committee

Karolina Faysman, RN, MSN, AOCNP, DNPc

Lead Hem/Onc Nurse Practitioner University of California, Los Angeles

Shawn Griffin, PharmD, BCOP

Oncology Pharmacist/Assistant Clinical Professor University of California, Irvine (UCI)

Facebook Twitter Dribbble Behance

Kristin Horwood, ACNP-BC, AOCNP, MSN

Nurse Practitioner University of Southern California

Facebook Twitter Dribbble Behance

Marilyn Douglas, MSN, FNP-BC, OCN

Executive Director of Nursing City of Hope National Medical Center

Facebook Twitter Dribbble Behance

Faculty Speakers

Dr. Korie Bigbee is an advanced practice provider with 15 years of experience in the hematology-bone marrow transplant setting. She earned her BSN from Dillard University in New Orleans and went on to earn her MSN and DNP from UCLA. She works for Kaiser Permanente at the City of Hope, providing acute care to patients receiving stem cell transplants. Although her immediate work involves caring for the patient in the early phase of their cancer journey, her passion is in providing comprehensive survivorship care for life after cancer. The focus of her doctoral project was to evaluate survivorship care practices, identify opportunities for growth, and create a standardized operating policy (SOP) for post-transplant survivorship care and management. Korie is driven by her desire to be survivorship’s game changer, but when she is not working, she finds her balance by spending time with her husband Matthew and three kids: Alysa, Isaiah, and Jonathan.

Dr. Doh is a board-certified oncology pharmacist with a clinical practice in malignant hematology and hematopoietic stem cell transplant and cellular therapy at the University of California Irvine Health and NCI-designated Chao Family Comprehensive Cancer Center. She received her Doctor of Pharmacy at the University of Wisconsin Madison followed by a PGY-1 Pharmacy Practice Residency and PGY-2 Oncology Pharmacy Residency at Henry Ford Hospital in Detroit, Michigan. Prior to joining UC Irvine Health, she practiced at Henry Ford as an Oncology Specialist and an Ambulatory Oncology Pharmacist at Kaiser Riverside where she accumulated valuable experiences establishing oncology pharmacist roles in investigational trial management, building oncology treatment plans in EPIC, and maintaining clinical responsibilities in a pharmacist-driven oral chemotherapy program, inpatient hematology, and a large-volume ambulatory infusion center. During her time so far at UC Irvine Health, she has been involved in establishing an ambulatory pharmacist clinic within a new bone marrow transplant program, creating and practicing under an extensive oncology pharmacist collaborative practice agreement, rounding with the inpatient hematology team, participating in research projects, and teaching at the UC Irvine School of Pharmacy. 

Blake Johnson is currently the Clinical Research Manager for Malignant Hematology and Oncology at UC Irvine’s Stern Center for Clinical Trials.  In his position, he manages a portfolio of over 70 clinical trials and supervises 12 clinical research staff who run the day to day administrative operations in the Chao Family Comprehensive Cancer Center Clinic.  The trials focus on immune therapies, specifically Bi-specific T-cell Engagers and Chimeric Antigen Receptor T-Cell therapy, and providing these important emerging treatment options to patients in critical need.   

Lora Johnstone is the Director of Advanced Practice Providers at UCLA Health.  She previously held the role of neonatal nurse practitioner supervisor and has been an active neonatal nurse practitioner for twenty three years at UCLA Health. Lora received her graduate degree from the University of California, San Francisco and her undergraduate degree from Loma Linda University.  Lora is a member of American Organization of Nursing Leadership, California Association of Nurse Practitioners and Academy of Neonatal Nurses.  Lora is also on the Board of Advisors for the Advanced Practice Provider Executives.  She is also involved in the Equity Diversity and Inclusion Nursing Council and participates as the mentor for the Advanced Practice Provider Council at UCLA Health.    

Lora is interested in building collaborating relationships to break down barriers that prevent APPs from achieving independent practice.  She is involved in improving patient access through the utilization of APPs, measuring APP productivity and improving patient outcomes through the use of APPs. In her spare time, Lora enjoys spending time with her husband and three sons, cycling, backpacking, hiking, snowboarding or enjoying a day at the beach.    

Erin Kopp is a doctorly prepared, nurse practitioner. She has practiced in hematology and bone marrow transplant for almost a decade. Currently, Erin is the Senior Manager of Advanced Practice at the City of Hope. Her specialty is follicular and T-cell lymphoma.

Tara Lacey, NP, MSN, is a Nurse Practitioner at the University of California, San Francisco in the Thoracic and Sarcoma Department and for the inpatient and Infusion Center of Stanford Medical Center specializing in patients with Hematology and Oncology malignancies. She has specialized in caring for patients with cancer for over 20 years and holds certificates in Gerontology Nurse Practitioner and Advanced Oncology Nurse Practitioner.
 
Ms. Lacey, a native of Ontario, Canada, earned her nursing degree from the University of Windsor and her master’s degree from the University of California, San Francisco with a specialty in oncology and gerontology. She has worked in multiple states throughout the country including Arizona, California, Oregon and Texas.
 
Ms Lacey is a published author, presenter and educator on various oncology/hematology topics including treatments, supportive care management and survivorship. She is a member of the Oncology Nursing Society and American Society of Clinical Oncology and has worked as a clinical faculty at San Francisco State University.

Sarah E. McBane, PharmD, BCPS, FCCP, FCPhA, FCSHP, APh is the Founding Associate Dean for Pharmacy Education and Health Sciences Clinical Professor within the Department of Clinical Pharmacy Practice at UC Irvine School of Pharmacy and Pharmaceutical Sciences. She is board-certified in Pharmacotherapy through the Board of Pharmaceutical Specialties. Dr. McBane’s clinical expertise is in ambulatory care family medicine, including women’s health and tobacco abuse. Dr. McBane is extensively involved in professional pharmacy organizations and is passionate about legislative and regulatory initiatives that expand the scope of pharmacy practice. She received her PharmD from the University of North Carolina at Chapel Hill and completed a Pharmacotherapy Specialty Residency in Family Medicine at East Carolina University.

Rowena Meyer, NP started and still currently works for City of Hope National Medical Center in Duarte, CA. She started her career as a Registered Nurse for 13 years before transitioning as a Nurse Practitioner, ongoing for 7 years, in the Medical Oncology Breast Department.

She enjoys Face to Face interactions with patients during clinic visits, and loves to serve as a resource for the Registered Nurses working in Clinics, Infusions, and Triage. 

On her off work days, she loves to spend time with her husband Alan, a dog named Cali, and 2 cats named Captain Picard and Commander Riker.

Jennifer Pugh, DNP, MSN, APRN CPNP, serves as the Executive Director & Associate Chief Nursing Officer for advanced practice & Pediatric Critical Care at Children’s Hospital Los Angeles (CHLA). With a strategic focus on leveraging practice, she is a catalyst for elevating healthcare standards through the promotion of collaborative partnerships among providers. Jennifer is an authentic leader known for cultivating strong interpersonal relationships uniting clinical teams, physicians, and other healthcare professionals to redesign and improve the local healthcare landscape.

Jennifer earned her Master’s and Bachelor’s degrees at California State University, Long Beach, initially working as a Pediatric Nurse Practitioner and Adjunct Faculty. In 2016, she transitioned her career towards leadership, culminating in the completion of her Doctorate in Nursing Practice degree in Executive Leadership.

Dr. Schiller is the Director of the Hematological Malignancy/ Stem Cell Transplant Program at the David Geffen School of Medicine at UCLA, supervising 200 transplants per year.  He has extensive clinical research experience, having conducted many investigator-initiated and multicenter trials, mostly in Hematologic Malignancies as well as Blood and Marrow Transplantation.  He is immediate past Chair of the Faculty Executive Committee for the School of Medicine at UCLA. He is an author of over 220 publications and 450 abstracts and presented in more than 350 events. He has mentored residents, medical students, and fellows for more than 30 years.  He has also served as a member and Chair of the Committee on Training for the American Society of Hematology and worked with its Trainee Council developing programs for the national meeting of the Society and curriculum for its Trainee Day and is presently Chair of the ASH Foundation committee. Dr. Schiller has an outstanding track record in clinical research, teaching, and mentoring and was co-investigator on Alternative Training grant for Bone Marrow Failure syndromes.  He also has extensive experience outside of medicine, with nonprofit, charitable institutions.  He has served on the Board of Trustees of Wilshire Boulevard Temple, and was Chairman of the Los Angeles Museum of the Holocaust. Dr. Schiller has 30 years of experience in the diagnosis and management of adults with Hematologic Malignancies and those undergoing allogeneic stem cell transplantation for non-malignant disorders including sickle cell disease.

As a radiation oncologist, Dr. Wei’s clinical practice focuses on the comprehensive care of children and adults with cancer. Dr. Wei received his medical and graduate degrees at the University of California, Irvine, as part of the Medical Scientist Training Program. He
then completed his internal medicine internship and radiation oncology residency at the University of California, Irvine. He trained with Dr. Nisar Syed and Dr. Ajmel Puthawala in interstitial brachytherapy and hyperthermia techniques. He served as Chief Resident for the final 2 years of residency.

Dr. Wei recognizes the unique needs of cancer patients and their families after his own father was treated for head and neck cancer. His philosophy on care is to empower his patients with education on their cancer and treatment options, enable patients and caregivers to make informed medical decisions, and provide them access to the most advanced radiation treatments such as intensity modulated radiotherapy, stereotactic radiosurgery, interstitial brachytherapy, and proton therapy.

Dr. Wei is a member of ASTRO, Los Angeles Radiological Society, American College of Radiation Oncology, and American Brachytherapy Society. In addition, he volunteers on the Medical Advisory Board for Make-A-Wish Orange County and Imperial Empire. Dr. Wei is on the medical staff at Long Beach and Saddleback Memorial Medical Center.

Laura J. Zitella is a Hematology Nurse Practitioner in the Hematology, Blood, Marrow Transplant, and Cellular Therapy (HBC) Program at UCSF Health and is an Associate Clinical
Professor in the Department of Physiological Nursing at the University of California San Francisco. She earned her Master of Science from the University of Illinois in Chicago. Laura holds certifications as an Acute Care Nurse Practitioner and an Advanced Oncology Certified Nurse.
With more than 25 years of experience in oncology practice, Ms. Zitella is recognized as a national nurse practitioner leader. Her clinical expertise includes patients with hematologic malignancies receiving chemotherapy, immunotherapy, targeted therapy, investigational agents, hematopoietic cell transplantation, cellular therapy, and supportive care. 

She is a prominent educator who has delivered hundreds of educational presentations to national and international audiences and authored numerous peer-reviewed publications, web courses, videos, and book chapters. She is a member of the Advanced Practitioner Society of Hematology and Oncology (APSHO), the Advanced Practice Provider Oncology Summit Planning Committee, the Association of Community Cancer Centers (ACCC), the California Association of Nurse Practitioners (CANP), the Oncology Nursing Society (ONS), the Society of Hematologic Oncology (SOHO), and the Society for Immunotherapy of Cancer (SITC).

"This is my first time attending the APPOS conference and I'm very impressed at how it is tailored specifically to APPs. I will definitely attend future conferences, hopefully in person."

Lindley M.

Accommodations

We want to ensure that your time at the APPOS Pasadena / Los Angeles 2024 conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.

Booking Deadline: December 18, 2023

Room rates:
Single Room Rate – $199++
++ refers to an addition of local taxes currently of 15% and a tourism assessment fee of 0.20%

Via phone, they can call 626-577-1000 or 1-800-HILTONS They would reference the Advanced Practice Providers Oncology Summit-Horizon CME name and provide the code: APP1.

Parking:

  • Hilton Valet Service is available at a special discounted group rate of $15.00 per day for event parking and this rate does not include in/out privileges. Prices are subject to change – We will have the discounted parking stamp available at the registration desk.
  • Overnight Valet Parking is also available at the rate of $24.00 per overnight stay and does include in/out privileges. Prices are subject to change.
  • The adjacent self-parking structure is open to the public. Current pricing for day visitors is $20 (overnight $25) per day and does not include in/out privileges. Prices are subject to change.

Disclaimer:
All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.

Click here to book your room today!